Literature DB >> 19340913

Needle track seeding: a real hazard after percutaneous radiofrequency ablation for colorectal liver metastasis.

Shirley Yuk-Wah Liu1, Kit-Fai Lee, Paul Bo-San Lai.   

Abstract

Neoplastic needle track seeding following percutaneous radiofrequency ablation (RFA) of secondary liver tumors is exceedingly rare. Reports on cutaneous tumor seeding after percutaneous RFA for colorectal liver metastasis are even rarer in the literature. Here we report a case of a 46-year-old female who developed an ulcerating skin lesion along the needle track of a previous percutaneous RFA site around 6 mo after the procedure. The previous RFA was performed by the LeVeen needle for a secondary liver tumor from a primary rectal cancer. The diagnosis of secondary skin metastasis was confirmed by fine needle aspiration cytology. The lesion was successfully treated with wide local excision. We believe that tumor seeding after percutaneous RFA in our patient was possibly related to its unfavorable subcapsular location and the use of an expansion-type needle. Hence, prophylactic ablation of the needle track should be performed whenever possible. Otherwise, alternative routes of tumor ablation such as laparoscopic or open RFA should be considered.

Entities:  

Mesh:

Year:  2009        PMID: 19340913      PMCID: PMC2669953          DOI: 10.3748/wjg.15.1653

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  10 in total

1.  Radiofrequency ablation of needle tract seeding in hepatocellular carcinoma.

Authors:  Sophie Espinoza; Patricio Briggs; Jean-Sébastien Duret; Matthieu Lapeyre; Thierry de Baère
Journal:  J Vasc Interv Radiol       Date:  2005-05       Impact factor: 3.464

2.  Transcatheter arterial embolization for tumor seeding in the chest wall after radiofrequency ablation for hepatocellular carcinoma.

Authors:  Toshiya Shibata; Toyomichi Shibata; Yoji Maetani; Takeshi Kubo; Naoshi Nishida; Kyo Itoh
Journal:  Cardiovasc Intervent Radiol       Date:  2006 May-Jun       Impact factor: 2.740

3.  Needle tract seeding after radiofrequency ablation of hepatic tumors.

Authors:  Jeffrey D Jaskolka; Murray R Asch; John R Kachura; Chia S Ho; Marc Ossip; Florence Wong; Morris Sherman; David R Grant; Paul D Greig; Steven Gallinger
Journal:  J Vasc Interv Radiol       Date:  2005-04       Impact factor: 3.464

4.  Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma.

Authors:  T Livraghi; S Lazzaroni; F Meloni; L Solbiati
Journal:  Br J Surg       Date:  2005-07       Impact factor: 6.939

5.  Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

Authors:  J M Llovet; R Vilana; C Brú; L Bianchi; J M Salmeron; L Boix; S Ganau; M Sala; M Pagès; C Ayuso; M Solé; J Rodés; J Bruix
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

6.  Thoracoabdominal wall tumour seeding after percutaneous radiofrequency ablation for recurrent colorectal liver metastatic lesion: a case report with a brief literature review.

Authors:  A Charalampopoulos; A Macheras; E Misiakos; A Batistatou; D Peschos; K Fotiadis; K Charalabopoulos
Journal:  Acta Gastroenterol Belg       Date:  2007 Apr-Jun       Impact factor: 1.316

7.  Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study.

Authors:  F Latteri; L Sandonato; V Di Marco; P Parisi; G Cabibbo; G Lombardo; M Galia; M Midiri; M A Latteri; A Craxì
Journal:  Dig Liver Dis       Date:  2008-02-21       Impact factor: 4.088

8.  Skin implant metastasis after percutaneous radio-frequency therapy of liver metastasis of a colorectal carcinoma.

Authors:  H Bonatti; G Bodner; P Obrist; O Bechter; G Wetscher; D Oefner
Journal:  Am Surg       Date:  2003-09       Impact factor: 0.688

9.  Radiofrequency ablation for subcapsular hepatocellular carcinoma.

Authors:  Ronnie Tung-Ping Poon; Kelvin Kwok-Chai Ng; Chi-Ming Lam; Victor Ai; Jimmy Yuen; Sheung-Tat Fan
Journal:  Ann Surg Oncol       Date:  2004-03       Impact factor: 5.344

Review 10.  Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC.

Authors:  R Stigliano; L Marelli; D Yu; N Davies; D Patch; A K Burroughs
Journal:  Cancer Treat Rev       Date:  2007-05-18       Impact factor: 12.111

  10 in total
  4 in total

1.  Evaluation of YO-PRO-1 as an early marker of apoptosis following radiofrequency ablation of colon cancer liver metastases.

Authors:  Sho Fujisawa; Yevgeniy Romin; Afsar Barlas; Lydia M Petrovic; Mesruh Turkekul; Ning Fan; Ke Xu; Alessandra R Garcia; Sebastien Monette; David S Klimstra; Joseph P Erinjeri; Stephen B Solomon; Katia Manova-Todorova; Constantinos T Sofocleous
Journal:  Cytotechnology       Date:  2013-09-25       Impact factor: 2.058

2.  Risk of needle tract seeding after coaxial ultrasound-guided percutaneous biopsy for primary and metastatic tumors of the liver: report of a single institution.

Authors:  Dagmar Schaffler-Schaden; Theresa Birsak; Ramona Zintl; Barbara Lorber; Gottfried Schaffler
Journal:  Abdom Radiol (NY)       Date:  2020-10

3.  Needle track seeding in colorectal carcinoma after local ablation by high-dose-rate brachytherapy: a retrospective study of 1,107 catheter placements.

Authors:  Christine March; Jazan Omari; Alexey Surov; Maximilian Thormann; Peter Hass; Maciej Pech; Robert Damm
Journal:  J Contemp Brachytherapy       Date:  2022-04-07

4.  Radiofrequency ablation of liver metastases from colorectal cancer: a literature review.

Authors:  Yasunori Minami; Masatoshi Kudo
Journal:  Gut Liver       Date:  2012-12-05       Impact factor: 4.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.